Yubin Miao Selected Research

Intravenous Injections

7/2018	Matched-pair, 86Y/90Y-labeled, bivalent RGD/bombesin antagonist, [RGD-Glu-[DO3A]-6-Ahx-RM2], as a potential theranostic agent for prostate cancer.
2/2015	Characterization and evaluation of DOTA-conjugated Bombesin/RGD-antagonists for prostate cancer tumor imaging and therapy.
2/2014	A heterodimeric [RGD-Glu-[(64)Cu-NO2A]-6-Ahx-RM2] αvβ3/GRPr-targeting antagonist radiotracer for PET imaging of prostate tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yubin Miao Research Topics

Disease

52	Melanoma (Melanoma, Malignant) 05/2023 - 02/2002
35	Neoplasms (Cancer) 04/2024 - 02/2002
5	Prostatic Neoplasms (Prostate Cancer) 07/2018 - 09/2011
3	Glioblastoma (Glioblastoma Multiforme) 07/2018 - 02/2014
2	Breast Neoplasms (Breast Cancer) 02/2014 - 08/2011

Drug/Important Bio-Agent (IBA)

56	Peptides (Polypeptides)IBA 05/2023 - 02/2002
36	alpha-MSHIBA 05/2023 - 02/2002
27	Type 1 Melanocortin ReceptorIBA 02/2022 - 11/2003
21	LactamsIBA 05/2023 - 02/2008
17	AcidsIBA 05/2023 - 08/2005
15	Melanocyte-Stimulating Hormones (MSH)IBA 01/2023 - 08/2009
14	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 02/2022 - 02/2002
11	Radioisotopes (Radionuclides)IBA 01/2021 - 02/2002
8	RadiopharmaceuticalsIBA 04/2024 - 07/2002
8	triazacyclononaneIBA 05/2023 - 06/2012
7	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 05/2023 - 06/2012
7	arginylprolineIBA 11/2014 - 04/2009
6	Amino Acids FDA Link 12/2014 - 10/2002
5	IntegrinsIBA 01/2021 - 11/2010
5	N-glycylglutamic acidIBA 06/2012 - 02/2008
4	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 05/2023 - 12/2014
4	Chelating AgentsIBA 12/2020 - 05/2009
4	MetalsIBA 01/2020 - 02/2002
4	Gonadotropin-Releasing Hormone (GnRH)FDA Link 10/2017 - 08/2011
4	arginyl-glycyl-aspartic acidIBA 04/2015 - 08/2009
3	cysteinylcysteineIBA 11/2014 - 09/2013
3	lysinenorleucineIBA 06/2012 - 04/2009
3	RheniumIBA 11/2007 - 02/2002
2	omega-aminocaprylic acidIBA 01/2023 - 12/2014
2	phenylalanylarginineIBA 01/2023 - 12/2020
2	1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA 12/2020 - 01/2020
2	BombesinIBA 07/2018 - 02/2015
2	tryptophylglycineIBA 06/2012 - 11/2009
2	Ac- Cys- Cys- Glu- His- D- Phe- Arg- Trp- Cys- Lys- Pro- Val- NH2IBA 11/2010 - 08/2006
2	Lysine (L-Lysine)FDA Link 11/2007 - 10/2002
2	Therapeutic UsesIBA 06/2007 - 01/2005
2	1,4,7,10-tetraazacyclododecane 1,4,7,10-tetraacetic acid (ReO- acetyl(Cys(3,4,10),Phe(7),Arg(7))alpha- MSH(3- 13))IBA 01/2007 - 04/2005
1	AlbuminsIBA 02/2022
1	Ethylene Glycol (Monoethylene Glycol)IBA 01/2022
1	Integrin alpha4beta1 (VLA-4)IBA 01/2021
1	Bombesin Receptors (Bombesin Receptor)IBA 02/2015
1	LigandsIBA 02/2015
1	HydrocarbonsIBA 12/2014
1	EDDA (NiEDDA)IBA 12/2014
1	MelanocortinsIBA 11/2014
1	aspartyllysineIBA 11/2013
1	alanylaspartic acidIBA 02/2012
1	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 08/2011
1	N- (2- aminoethyl)- 1,2- diaminocyclohexane- N,N',N''- pentaacetic acid-Re(Cys(3,4,10))-Phe(7)-Arg(11)- alpha-MSH(3-13)IBA 05/2009
1	N- (2- amino- 3- (4- isothiocyanatophenyl)propyl)cyclohexane- 1,2- diamine- N,N',N',N'',N''- pentaacetic acidIBA 05/2009
1	Deoxyglucose (2 Deoxy D glucose)IBA 04/2009
1	ACTH (7-10)IBA 04/2009
1	Melanins (Melanin)IBA 09/2008
1	PlacebosIBA 06/2007
1	AntigensIBA 03/2007
1	Biomarkers (Surrogate Marker)IBA 03/2007
1	Peptide LibraryIBA 03/2007
1	StreptavidinIBA 03/2007
1	Glutamic Acid (Glutamate)FDA Link 08/2006
1	Oxygen (Dioxygen)IBA 08/2005
1	OF 900IBA 11/2003
1	Indium-111IBA 02/2002

Therapy/Procedure

20	Therapeutics 01/2023 - 10/2002
3	Precision Medicine 04/2024 - 07/2018
3	Intravenous Injections 07/2018 - 02/2014
3	Radiotherapy 02/2014 - 02/2002
1	Aftercare (After-Treatment) 01/2005